HIGHLIGHTS
- who: Shih-Jen Chang et al. from the Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School have published the research work: Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas, in the Journal: Pharmaceutics 2022, 1607 of /2022/
- what: The authors aimed to develop a superior skin permeation drug while maintaining the therapeutic properties of timolol. The authors demonstrated that skin permeation and retention of BT were superior to that of TM in both in_vivo and ex vivo environments, whilst achieving . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.